ADORA2A and breast neoplasm: On the other hand, Powe et al. described that α2C-AR are highly expressed in breast tumors with a more aggressive phenotype, which is in line with our previous observation where α2-AR binding sites were higher in tumor breast cell lines in comparison with the non-tumorigenic cells [18].